about
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.Dimethyl fumarate for multiple sclerosis.Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.Daclizumab for the treatment of multiple sclerosis.Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline.Teriflunomide for oral therapy in multiple sclerosis.Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial.Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial.Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.Fatigue and progression of corpus callosum atrophy in multiple sclerosis.Decision for intravenous thrombolysis in a young patient with acute vertical gaze palsy.Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study.Detection of cerebrospinal fluid leaks by intrathecal contrast-enhanced magnetic resonance myelography.Unilateral leg oedema due to spontaneous Achilles tendon rupture.MRI characteristics of periaqueductal lesions in multiple sclerosisIntrathecal Gadolinium for Magnetic Resonance Myelography in Spontaneous Intracranial Hypotension: Valuable But May Be Risky—ReplyCortical Thickness Alterations in Chronic Pain DisorderIsolated oculomotor palsy due to acute ischemic midbrain strokeEvolution of MS lesions to black holes under DNA vaccine treatmentDiagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: Results of an international surveyFrequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disordersElectronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trialsShort timescale modulation of cortical and cerebellar activity in the early phase of motor sequence learning: an fMRI studyOptimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international studyAttack-related damage of thalamic nuclei in neuromyelitis optica spectrum disordersDamage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathwayOptic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders[Optical Coherence Tomography in Disorders of the Central Nervous System]
P50
Q34104397-6F6BF990-6233-41B1-A984-A718DAA1CF17Q37808485-7E135703-BDF0-4BD2-8709-0EDC5277A3DEQ38357590-FEDDEC1E-8796-4D69-BBFB-BEEB0D799112Q38604207-0705BC8D-45C4-40F6-933E-B4236B658D9EQ38859250-B7294252-3C6F-459C-9E03-F437B80BD9A3Q39504360-AE964E11-F98D-49DA-93BD-B4EFEF2C8D7DQ39641399-1FD7DD7B-B05A-42C4-B543-50762ECCC27FQ44635866-7E355967-C234-4030-9E46-E3A113C2C9BEQ45916675-0D9F410E-4B2B-4C29-83C5-8A221C00BA0EQ46866052-17BABF09-8DF3-4C62-ADBC-2F9C0F28BBF2Q47556575-073B5E9D-76EB-4453-9EDA-6B21E15D1CF1Q47574430-1D29AC54-9BF6-412B-BFE0-70797843E90CQ48146149-ACD7274E-D69B-44D7-8A63-0FF77FEF2B35Q51461532-B0C74BF9-3054-49E5-BF77-346D87FA2428Q53053197-366B78A5-9D39-4C59-A027-95CF5B9D3AE4Q54193068-D692F173-D60C-4576-8F68-70DDD1B802D0Q54684987-9B741CF7-2F2C-436A-B0AB-F1381D79E94BQ55347093-E1EF3FC9-0276-4070-B1CB-B0907BE57D9FQ60681787-AEF03618-777F-4CE8-B790-6F514924C58EQ60681788-609EDB27-6A1F-4E09-90FB-83EED9B185E3Q61971651-604398A0-F87E-4024-A750-0FE12EEFD1DCQ61971652-7BE1302B-A704-4FE6-9BB9-F3E242C8DC5CQ61971664-D111C06B-58AC-4667-9DB0-84786F61BBA6Q90369364-29F38224-415A-4187-9CEF-94C9CE741498Q91539054-A0241CE9-788E-45BD-9984-E4E8124CD6D1Q91797501-9715BA86-97D8-4B64-B955-23EA36A60239Q92227356-3163C18E-3126-4322-AD37-23FF7F69610BQ92239550-65D7877D-B01D-44FC-899D-92506CC794C2Q92281918-FDEBCAFB-728E-4B77-9E91-9031BBD2029FQ93010979-428B3B1C-3739-4BF2-B02A-30C1BF3F9587Q93232460-6BD4FEF3-4992-4D0D-8A37-47F7A8C80824Q93243290-F0D08372-A575-489F-828C-C261F58E13FA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Athina Papadopoulou
@ast
Athina Papadopoulou
@en
Athina Papadopoulou
@es
Athina Papadopoulou
@nl
Athina Papadopoulou
@sl
type
label
Athina Papadopoulou
@ast
Athina Papadopoulou
@en
Athina Papadopoulou
@es
Athina Papadopoulou
@nl
Athina Papadopoulou
@sl
prefLabel
Athina Papadopoulou
@ast
Athina Papadopoulou
@en
Athina Papadopoulou
@es
Athina Papadopoulou
@nl
Athina Papadopoulou
@sl
P106
P21
P31
P496
0000-0002-0367-1008